Cargando…
Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episo...
Autores principales: | Finsterer, Josef, Nics, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/ https://www.ncbi.nlm.nih.gov/pubmed/34901793 http://dx.doi.org/10.1016/j.hest.2021.12.001 |
Ejemplares similares
-
Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
por: Finsterer, Josef
Publicado: (2022) -
Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases
por: Finsterer, Josef, et al.
Publicado: (2021) -
SARS-CoV-2 may underlie NMDA-related autoimmune encephalitis and venous sinus thrombosis
por: Finsterer, Josef
Publicado: (2023) -
Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Before blaming SARS-CoV-2 for venous sinus thrombosis in a septic patient, consider alternative etiologies
por: Finsterer, Josef, et al.
Publicado: (2023)